ADO Charting and Technical Analysis, page-548

In my conservative opinion, I'd like to think we'll probably only make $1 profit per test. I too have been hearing the $5 amount thrown out there but not sure if that's a bit optimistic, considering we will be selling these wholesale, so the retailer/distributor will need to make something on top as well.

I'm also not sure if we'll be selling these tests for $30 a pop, Ellume might, but with our test, Axxin reader is required, therefore, whoever is to administrate the test will be bulk buying our Covid ART, and they will probably want to make something on top of that too.

So again, being conservatively, I'd say we'll sell them for about $10ish.

As for holdings and selling, I've accumulated over 2m shares in the last 8 years, and I do agree with@Peekay, the higher it goes, the more stressed I get with it, just the fact that there's more to lose. But for me, I know one day, I will eventually sell a portion of it to fund my next house, don't think I have the courage to hold everything until dividends - though a steady SP with proven long term revenue/profits will easily change that.